Literature DB >> 33841932

Adult pectus excavatum repair: national outcomes of the Nuss and Ravitch procedures.

Joseph G Brungardt1, Patrick W Chizek1, Kurt P Schropp1.   

Abstract

BACKGROUND: National data is limited on pectus excavatum, the most common chest wall deformity which is often repaired using the Ravitch and Nuss procedures. The purpose of the study was to describe demographics and outcomes of adult patients who underwent surgical repair of pectus excavatum via open and minimally invasive thoracoscopic methods.
METHODS: A retrospective analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database from 2015 to 2018 was performed, capturing patients 18 years or older with pectus excavatum as the postoperative diagnosis. Patients were placed into two groups of minimally invasive (Nuss) and open (Ravitch) repair procedure code. Baseline characteristics and postoperative outcomes were analyzed.
RESULTS: A total of 168 adult patients were captured. Most of these patients were white (84.52%) male (69.64%) and 26 years old on average. Median operative time was longer in the open repair group [250 (IQR, 173-308) versus 122 (IQR, 94-160) minutes, P<0.0001]. Median length of stay was five days (IQR, 4-6) in the open group and three days (IQR, 2-4) in the minimally invasive group (P=0.2873).
CONCLUSIONS: Complications after repair of pectus excavatum occur at similar rates between open and minimally invasive repair. Though minimally invasive repair decreases operative time and may decrease length of stay, the decision of type of procedure depends upon clinical scenario and factors unique to the individual patient. 2021 Journal of Thoracic Disease. All rights reserved.

Entities:  

Keywords:  Nuss; Pectus excavatum; Ravitch; chest wall; pediatric; sunken chest

Year:  2021        PMID: 33841932      PMCID: PMC8024841          DOI: 10.21037/jtd-20-2422

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   3.005


Introduction

Depression of the sternum, known as pectus excavatum, or “sunken chest”, is the most common chest wall deformity in children with an incidence of 1 in 400 births (1). This can affect the cardiopulmonary function, cause chest pain, dyspnea, and exercise intolerance in some patients (2). Furthermore, it can cause social anxiety and psychological distress from dissatisfaction or anxiety with body image. For these reasons, correction is typically recommended (3). The repair described by Dr. Ravitch in 1949 built upon previous descriptions by a number of surgeons and utilized an open, midline, incision with osteotomy and cartilaginous resection (4-7). These repairs generally fell out of favor upon the introduction of the Nuss procedure, introduced to the public in 1998, which utilized lateral chest wall incisions and a stainless steel bar to invert the sunken chest (8). These repairs eventually became well studied in the pediatric population. The Nuss procedure has been shown to have less blood loss and lower operative time, as well as possibly a shorter length of stay, strong patient satisfaction, lower blood transfusion, and lower overall complication rate (9-12). Reoperation will be necessary for the Nuss procedure to remove the bar, if the bar migrates, and has been associated with a higher rate of hemopneumothorax (10). Nuss procedures in adults have excellent outcomes with good cosmesis using the minimally invasive approach and possibly two bars (13). National data on these procedures in adults are lacking, limited to these institutional cohorts. We sought to describe the population receiving the Nuss and Ravitch procedures as adults and their immediate outcomes. We hypothesized that operative times for open procedures would be longer, while length of stay, mortality, return to the operating room, and readmission would be similar. We present the following article in accordance with the STROBE reporting checklist (available at http://dx.doi.org/10.21037/jtd-20-2422).

Methods

The study used data from the American College of Surgeons National Quality Surgical Improvement Program (ACS NSQIP), from years 2015 to 2018 (14). The program collects patient-level, aggregate data, and is Health Insurance Portability and Accountability Act (HIPAA)-compliant (does not identify location, physician, patient). ACS NSQIP participating hospitals can obtain this data for free. This dataset benefits the researcher by collecting granular data of specific outcomes and risk factors. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved as exempt non-human subjects research by the Institutional Review Board of the University of Kansas Medical Center. The study included all patients 18 years of age and older with a postoperative diagnosis of pectus excavatum, according to the International Classification of Diseases ninth and tenth editions. These codes were 754.81 or Q67.6. We excluded patients undergoing other major unrelated operations. Patients were then stratified into two groups, those who underwent open repair (Open, 43 patients) versus minimally invasive repair (MIS, 125 patients), by current procedural terminology coding (). The open procedure codes were considered Ravitch procedures while minimally invasive codes were considered Nuss procedures. The variables compared included comorbidities, preoperative variables, wound class, and other matching variables. Outcomes examined included complications, mortality, length of operation, length of stay, discharge destination, and readmission. Other common 30-day outcomes were captured.
Table 1

Demographics and comorbidities of adult patients undergoing Ravitch or Nuss procedures

CharacteristicTotalOpenMISP value
n%n%n%
Total1684325.60%12574.40%
Age (years)*26.021–3526.023–4126.020–340.1059
Sex
   Male11769.64%2762.79%9072.00%0.2573
   Female5130.36%1637.21%3528.00%0.2573
Race
   White14284.52%4297.67%10080%0.0057
   Black31.79%12.33%21.60%1.0000
   Hispanic95.36%24.65%75.60%1.0000
   Not reported148.33%00.00%1411.20%0.0219
Comorbidities
   Diabetes00.00%00.00%00.00%1.0000
   Current smoker116.55%12.33%108.00%0.3393
   No dyspnea7947.02%1739.53%6249.60%0.2540
   COPD00.00%00.00%00.00%1.0000
   HTN31.79%24.65%10.80%0.1613
   Weight loss10.60%00.00%10.80%1.0000
   Steroid use00.00%00.00%00.00%1.0000
   Independent16799.40%4297.67%125100.00%0.0873
   Body mass index (kg/m2)22.3±3.7922.7±4.5922.1±3.490.4173
   ASA 3 or greater2514.88%818.60%1713.60%0.4264

Values are mean ± SD or N (%). *Median (quartile 1–quartile 3).

Values are mean ± SD or N (%). *Median (quartile 1–quartile 3).

Statistical analysis

Chi-square test or two-sample t-test, using Fisher’s exact test where necessary, were used to compare baseline characteristics. The same tests were used to analyze postoperative outcomes. Low sample size and homogeneity between preoperative variables precluded the ability to carry out multivariable regression modeling. Statistical analysis and data management were performed using Excel (from Microsoft version 16.32) and SPSS (IBM Corp. IBM SPSS Statistics for Windows, Version 23.0. Armonk, NY, USA: IBM Corp.). Significance is indicated by P<0.05.

Results

A total of 168 patients were included in the study, 43 (25.6%) undergoing open (Ravitch) repair, and 125 (74.4%) undergoing minimally invasive (Nuss) repair. These patients had a median age of 26 years (range 18-61 years), 117 were male (69.64%), 142 were white (84.52%), and had similar rates of comorbidities such as diabetes and hypertension (). Among them, 15% of patients were American Society of Anesthesiology (ASA) class three or higher. There were no statistical differences in preoperative demographics such as age, race, sex, or comorbidities such as hypertension, body mass index (range, 16–40 kg/m2), or ASA class between groups. The majority of these procedures were elective, 166 (98.81%) (). Open procedures were more likely to occur in the first admission quarter, while the minimally invasive repair was more likely to occur in the fourth admission quarter. Preoperative labs were clinically similar, though sodium and INR were statistically different between groups. An analysis of surgeon specialty showed 81.55% of these procedures were performed by cardiothoracic surgeons in both groups ().
Table 2

Perioperative variables of adult patients undergoing Ravitch or Nuss procedures

VariableTotalOpenMISP value
n%n%n%
Total1684325.60%12574.40%
Elective operation16698.81%43100%12398.40%0.4040
Admission quarter
   14627.38%1739.53%2923.20%0.0383
   24023.81%1330.23%2721.60%0.2516
   35130.36%1227.91%3931.20%0.6854
   43118.45%12.33%3024.00%0.0016
Wound class
   Clean16497.62%4297.67%12297.60%0.9780
   Clean/contaminated31.79%12.33%21.60%1.0000
   Contaminated10.60%00.00%10.80%1.0000
   Dirty/infected00.00%00.00%00.00%1.0000
Preoperative Labs
   Sodium (mEq/L)140.2±2.1139.6±2.2140.4±2.10.0497
   BUN (mmol/L)13.7±3.713.5±3.513.8±3.80.6346
   Creatinine (mg/dL)0.9±0.20.9±0.20.9±0.20.4165
   Albumin (g/dL)4.6±0.44.6±0.44.7±0.30.6028
   Bilirubin (mg/dL)0.8±0.50.7±0.40.9±0.60.3408
   AST (μ/L)19.6±4.218.5±3.320.7±4.80.1970
   ALP (μ/L)69.1±26.062.2±14.876.0±33.00.1858
   WBC (×109/L)6.2±1.86.5±1.66.1±1.80.2264
   HCT (percent)43.2±3.743.5±3.643.1±3.70.5386
   PLT (K/L)234.2±50.8238.8±49.5232.4±51.40.5088
   PTT (seconds)29.2±2.730.0±2.928.9±2.60.0804
   INR1.1±0.11.0±0.11.1±0.10.0315

Values are mean ± SD or N (%).

Table 3

Surgeon specialty of adult patients undergoing Ravitch or Nuss procedures

Surgeon specialtyTotalOpenMISP value
n%n%n%
Total1684325.60%12574.40%
Cardiothoracic13781.55%3786.05%10080.00%0.3780
General surgery3118.45%613.95%2520.00%0.3780

Values are N (%).

Values are mean ± SD or N (%). Values are N (%). describes postoperative outcomes between groups. Time to operation and length of stay were statistically similar, though the median length of stay was five days in the open group and three days in the minimally invasive group (P=0.2873) (2–5 days interquartile range). One 30-day mortality was observed in the minimally invasive group. Median operative time was 128 minutes longer in the open repair group, P<0.0001. Median operative time was statistically different between Open and MIS repair, 250 minutes versus 122 minutes, respectively, P<0.0001. Readmission, reoperation, and inpatient complications were similar between groups. Return to the operating room was noted in three minimally invasive cases for hemorrhage (1), hematoma (1), and other postoperative complication (1). The other three diagnoses for returns to the operating room were not identified. Readmission was noted in one minimally invasive patient for a postprocedural complication of the skin and subcutaneous tissue and one open surgical patient for pleural effusion. All patients were discharged to home.
Table 4

Perioperative outcomes of adult patients undergoing Ravitch or Nuss procedures

VariableTotalOpenMISP value
n%n%n%
Total1684325.60%12574.40%
Hospital days to operation0.01±0.110.00±0.000.02±0.130.1581
Hospital length of stay (days)*3.02,55.04,63.02,40.2873
30-day mortality10.59%00.00%10.80%1.0000
Operative time (minutes)*133100–193250173–30812294–160<0.0001
Complication
   Readmission21.19%12.33%10.80%0.4475
    Related to operation21.19%12.33%10.80%0.4475
   Return to operating room63.57%24.65%43.20%0.6465
    Related to operation63.57%24.65%43.20%0.6465
   Unplanned intubation00.00%00.00%00.00%1.0000
   On ventilator >48 hours00.00%00.00%00.00%1.0000
   Wound infection (superficial)10.60%00.00%10.80%1.0000
   Wound infection (deep)00.00%00.00%00.00%1.0000
   Organ space SSI00.00%00.00%00.00%1.0000
   Wound dehiscence00.00%00.00%00.00%1.0000
   Pneumonia00.00%00.00%00.00%1.0000
   Urinary tract infection10.60%12.33%00.00%0.2560
   DVT00.00%00.00%00.00%1.0000
   Pulmonary embolism00.00%00.00%00.00%1.0000
   Cardiac arrest requiring CPR10.60%00.00%10.80%1.0000
   Myocardial infarction00.00%00.00%00.00%1.0000
   Sepsis00.00%00.00%00.00%1.0000
   Shock00.00%00.00%00.00%1.0000
   Bleeding transfusion00.00%00.00%00.00%1.0000
   Renal complications00.00%00.00%00.00%1.0000
Discharge destination (home)168100%43100%125100%1.0000

Values are mean ± SD or N (%). *Median (quartile 1–quartile 3).

Values are mean ± SD or N (%). *Median (quartile 1–quartile 3).

Discussion

This analysis shows the clinical outcomes of adult patients undergoing surgical correction of pectus excavatum at ACS NSQIP participating institutions. The difference in length of stay between open and minimally invasive approach was statistically similar, but may still be clinically different, five days versus three days, respectively. Operative time, unsurprisingly, was longer for the open procedures, likely due to these operations being more extensive than the Nuss repair. This analysis should provide support to the surgeon, who shares decision making between the two procedures with patients. Furthermore, the analysis continues to add to the growing body of literature of pediatric patients with pathologies who may require surgical interventions as adults. This study represents the largest national cohort of adult patients undergoing repair of pectus excavatum. The results support our hypothesis that operative times would be longer for the Ravitch procedure but otherwise similar clinical outcomes between groups. Not captured in this study were those patients undergoing repeat operations. This could not stratify what patients were undergoing the Ravitch procedure due to a failed Nuss bar earlier in life, those undergoing a repeated Nuss procedure, or electively undergoing either the Ravitch or Nuss procedure primarily. The use and time of chest tubes were not captured. Haller, or pectus index, and morphology were also not captured. Pain and nausea, an important component of the move towards minimally invasive repair, was not captured in this data. Long term follow-up to assess durability and satisfaction with repair are not included either. These are all important variables to consider when planning a repair and presenting the options to a patient. The retrospective nature of the study, the limitations inherent to the database, and the inherent differences between specialties’ approaches, limit the study. Furthermore, ACS NSQIP acknowledges several limitations inherent to the database (14). Patients are followed for only 30 days, variables are fairly generic and don’t tell a larger story, and participating hospitals are the data contributors. Case complexity, prior operations, and other similar clinically relevant data is unavailable. Outcomes of cosmesis and long-term recurrence is not available. Hospital and surgeon volume is unavailable, which would allow for more control over variables. Sampling error is somewhat eliminated but complete removal of bias isn’t possible. The database does allow for analysis of trends that other databases may not allow for and may avoid some bias as described by LaPar and colleagues (15). Nuss repair, while the preferred method of repair in children, may be a less attractive option in adults undergoing repair of pectus excavatum due to decreased pliability of the chest wall. Some surgeons may want to offer a patient an open or Ravitch procedure due to clinical reasons but are uncertain of outcomes. This study supports those surgeons with data on the two procedures. Further research continues to be necessary to study the pediatric to adult continuum of surgical pathology, including pectus excavatum. The article’s supplementary files as
  12 in total

1.  The operative treatment of pectus excavatum.

Authors:  M M RAVITCH
Journal:  J S C Med Assoc       Date:  1955-07

2.  The surgical treatment of funnel chest.

Authors:  C W LESTER
Journal:  Ann Surg       Date:  1946-06       Impact factor: 12.969

Review 3.  Chest wall deformities in pediatric surgery.

Authors:  Robert J Obermeyer; Michael J Goretsky
Journal:  Surg Clin North Am       Date:  2012-04-17       Impact factor: 2.741

Review 4.  Comparison of the Nuss versus Ravitch procedure for pectus excavatum repair: an updated meta-analysis.

Authors:  Yong Zhong Mao; ShaoTao Tang; Shuai Li
Journal:  J Pediatr Surg       Date:  2017-06-03       Impact factor: 2.545

Review 5.  Comparison of the Nuss and the Ravitch procedure for pectus excavatum repair: a meta-analysis.

Authors:  Ahmed Nasr; Annie Fecteau; Paul W Wales
Journal:  J Pediatr Surg       Date:  2010-05       Impact factor: 2.545

6.  A 10-year review of a minimally invasive technique for the correction of pectus excavatum.

Authors:  D Nuss; R E Kelly; D P Croitoru; M E Katz
Journal:  J Pediatr Surg       Date:  1998-04       Impact factor: 2.545

7.  The minimally invasive Nuss technique for recurrent or failed pectus excavatum repair in 50 patients.

Authors:  Daniel P Croitoru; Robert E Kelly; Michael J Goretsky; Tina Gustin; Rebecca Keever; Donald Nuss
Journal:  J Pediatr Surg       Date:  2005-01       Impact factor: 2.545

8.  Nuss procedure for repair of pectus excavatum after failed Ravitch procedure in adults: indications and caveats.

Authors:  Gregor J Kocher; Nathalie Gstrein; Dawn E Jaroszewski; Mennatallah M Ewais; Ralph A Schmid
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

9.  Upper thoracic shape in children with pectus excavatum: impact on lung function.

Authors:  Gregory J Redding; Wieying Kuo; Jonathan O Swanson; Grace S Phillips; Julia Emerson; Delphine Yung; Jordan W Swanson; Robert S Sawin; Jeffrey R Avansino
Journal:  Pediatr Pulmonol       Date:  2012-08-21

10.  Routine use of minimally invasive surgery for pectus excavatum in adults.

Authors:  Hans K Pilegaard; Peter B Licht
Journal:  Ann Thorac Surg       Date:  2008-09       Impact factor: 4.330

View more
  2 in total

1.  Complications following metal bar removal after Nuss repair are rare in a duocentric retrospective evaluation.

Authors:  Stephan Rohleder; Andreas C Heydweiller; Tatjana T König; S Tolga Yavuz; Martin Schwind; Christina Oetzmann von Sochaczewski
Journal:  Pediatr Surg Int       Date:  2022-09-22       Impact factor: 2.003

2.  Reshaping the Evidence for Surgical Correction of Pectus Excavatum Using Cardiopulmonary Exercise Testing.

Authors:  Ashok Kar; Max Baghai; Ian Hunt
Journal:  J Am Heart Assoc       Date:  2022-04-04       Impact factor: 6.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.